Prognostic factors and long term evolution in a cohort of 133 patients with giant cell arteritis

Clinical and Experimental Rheumatology

Volumn 19, Issue 2, 2001, Pages 171-176

  Hachulla, E ^a   Boivin, V ^a   Pasturel Michon, U ^a   Fauchais, A L ^a   Bouroz Joly, J ^a   Perez Cousin, M ^a   Hatron, P Y ^a   Devulder, B ^a  

^a UNIV LILLE   (France)

Author keywords

Giant cell arteritis; Prognosis; Survival

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; PREDNISOLONE; PREDNISONE; STEROID;

ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; BIOPSY; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; DOSE RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; EVOLUTION; FAMILY; FEMALE; GENDER; GENERAL PRACTITIONER; GIANT CELL ARTERITIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT; POPULATION; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SURVIVAL; TEMPORAL ARTERY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RECURRENCE; REGISTRIES; SURVIVAL ANALYSIS; TEMPORAL ARTERITIS;

EID: 0035032825     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Predictors and response treatment
2. Elastase derived elastinpeptides putative autoimmune targets in giant cell arteritis
3. Long term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort
4. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy
5. Temporal arteritis: A 14-year epidemiological, clinical and prognostic study
6. Evolution, traitement et pronostic de la maladie de Horton
7. Excess mortality in giant cell arteritis
8. Les décès dans la maladie de Horton. Facteurs de pronostic
9. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: A useful test in the management of the disease
10. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
11. Giant cell arteritis and polymyalgia rheumatica
12. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis
13. Polymyalgia rheumatica duration of therapy and long-term outcome
14. Polymyalgia rheumatica and giant cell arteritis
15. Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: A retrospective study
16. Pharmacocinétique sérique comparée de la prednisone et du méthylsulfobenzoate de prednisolone après administration orale
17. Polymyalgia rheumatica and temporal arteritis: A retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients)